These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1346 related items for PubMed ID: 16087714

  • 1. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.
    Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR.
    J Exp Med; 2005 Aug 15; 202(4):473-7. PubMed ID: 16087714
    [Abstract] [Full Text] [Related]

  • 2. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.
    Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.
    Brain; 2007 May 15; 130(Pt 5):1194-205. PubMed ID: 17282996
    [Abstract] [Full Text] [Related]

  • 3. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T, Fujihara K, Itoyama Y.
    Brain Nerve; 2008 May 15; 60(5):527-37. PubMed ID: 18516975
    [Abstract] [Full Text] [Related]

  • 4. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.
    Rinsho Byori; 2009 Mar 15; 57(3):262-70. PubMed ID: 19363997
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.
    Brain; 2007 May 15; 130(Pt 5):1224-34. PubMed ID: 17405762
    [Abstract] [Full Text] [Related]

  • 8. Neuromyelitis optica.
    Matiello M, Jacob A, Wingerchuk DM, Weinshenker BG.
    Curr Opin Neurol; 2007 Jun 15; 20(3):255-60. PubMed ID: 17495617
    [Abstract] [Full Text] [Related]

  • 9. Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.
    Cayrol R, Saikali P, Vincent T.
    Ann N Y Acad Sci; 2009 Sep 15; 1173():478-86. PubMed ID: 19758189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential regulation of IgG-NMO autoantibodies on S100Beta protein and disability in relapsing neuromyelitis optica.
    Robinson-Agramonte MA, Gonçalves CA, Portela LV, Saiz-Hinarejos A, Oses JP, Motta LS, Muller AP, Marquez Gonzalez ME, Souza DO.
    Neuroimmunomodulation; 2010 Sep 15; 17(3):177-9. PubMed ID: 20134196
    [Abstract] [Full Text] [Related]

  • 12. Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies.
    Nicchia GP, Mastrototaro M, Rossi A, Pisani F, Tortorella C, Ruggieri M, Lia A, Trojano M, Frigeri A, Svelto M.
    Glia; 2009 Oct 15; 57(13):1363-73. PubMed ID: 19229993
    [Abstract] [Full Text] [Related]

  • 13. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
    Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y.
    Neurology; 2009 Jun 02; 72(22):1960-1. PubMed ID: 19487655
    [No Abstract] [Full Text] [Related]

  • 14. Aquaporins, anti-aquaporin-4 autoantibodies and neuromyelitis optica.
    González C, González-Buitrago JM, Izquierdo G.
    Clin Chim Acta; 2013 Jan 16; 415():350-60. PubMed ID: 22580368
    [Abstract] [Full Text] [Related]

  • 15. [NMO-IgG antibodies in neuromyelitis optica: a report of 2 cases].
    Zuliani L, López de Munain A, Ruiz Martínez J, Olascoaga J, Graus F, Saiz A.
    Neurologia; 2006 Jan 16; 21(6):314-7. PubMed ID: 16799907
    [Abstract] [Full Text] [Related]

  • 16. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.
    Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.
    Arch Neurol; 2009 Sep 16; 66(9):1164-7. PubMed ID: 19752309
    [Abstract] [Full Text] [Related]

  • 17. Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.
    Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):623-7. PubMed ID: 19545538
    [Abstract] [Full Text] [Related]

  • 18. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 04; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 19. Neurological autoimmunity targeting aquaporin-4.
    Hinson SR, McKeon A, Lennon VA.
    Neuroscience; 2010 Jul 28; 168(4):1009-18. PubMed ID: 19699271
    [Abstract] [Full Text] [Related]

  • 20. [Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].
    Jordan B, Eger K, Kornhuber ME, Zierz S.
    Fortschr Neurol Psychiatr; 2008 Jan 28; 76(1):21-7. PubMed ID: 18189220
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 68.